HTLV-I and HTLV-II peptide antigens and methods

Details HTLV-I and HTLV-II peptide antigens and methods HTLV-I and HTLV-II peptide antigens and methods

1995-06-07

1999-07-27

Smith, Lynette F.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

435 71, C12Q 170, G01N 3353, G01N 33567

Patent

active

059288612

ABSTRACT:
Novel HTLV-I and HTLV-II peptide antigens are disclosed for use in diagnostics assays for screening and confirming HTLV-I and HTLV-II antisera. The peptides are derived from analogous regions of HTLV-I and HTLV-II gp46 envelop proteins, and are differentiated by their immunoreactivity with an HTLV-II specific monoclonal antibody and by HTLV-I and HTLV-II antisera. The peptides are also useful in vaccine compositions.

REFERENCES:
patent: 4446122 (1984-05-01), Chu et al.
patent: 4588681 (1986-05-01), Sawada et al.
patent: 4645738 (1987-02-01), Knowles et al.
patent: 4661445 (1987-04-01), Saxinger et al.
patent: 4663436 (1987-05-01), Elder et al.
patent: 4689398 (1987-08-01), Wu et al.
patent: 4722888 (1988-02-01), Broder et al.
patent: 4724258 (1988-02-01), Yoshida et al.
patent: 4731326 (1988-03-01), Thompson et al.
patent: 4735896 (1988-04-01), Wang et al.
patent: 4743678 (1988-05-01), Essex et al.
patent: 4757000 (1988-07-01), Tohmatsu et al.
patent: 5003043 (1991-03-01), Akita et al.
patent: 5017687 (1991-05-01), Vahlne et al.
patent: 5039604 (1991-08-01), Papsidero
patent: 5066579 (1991-11-01), Reyes
Matsushita, et al., 1986, "Human monoclonal antibody directed against . . . " PNAS 83: 2672-2676.
Anderson, D.W. et al., MMWR 37,48:737-747 (1988).
Anderson, D.W. et al., Blood 74, 2585-2591 C1989).
Blattner, W.A. et al., Int. J. Cancer 30:257-264 (1982).
Blattner, W.A. et al., JAMA 250,8:1074-1080 (1983).
Blayney, D.W. et al., JAMA 250,8:1048-1052 (1983).
Catovsky, D. et al., Lancet, 1,8273:639-643 (1982).
Chen, Y-M. A. et al., J. Virology 63,11:4952-4957 (1989).
Chen, Y-M. A. et al., Lancet 336:1153-1155 (1990).
Chiba, J. et al., Proc. Natl. Acad. Sci. USA 88:4641-4645 (1991).
Cianciolo, G.J. et al., Science 230;453-455 (1985).
Clapham, P. et al., Proc Natl. Acad. Sci. USA 81:2886-2889 (1984).
Essex, M. et al., Science 221:1061-1064 (1983).
Gallo, R.C. et al., Proc. Natl. Acad. Sci. USA 79:5680-5683 (1982).
Gallo, R.C. et al., Cancer Res. 43:3892-3899 (1983).
Halbert, S.P. et al., J. Clin. Microbiol. 23,2:212-216 (1986).
Hattori, S. et al., Virology 136:338-347 (1984).
Horal, P. et al., Proc. Natl. Acad. Sci. USA 88:5754-5877 (Jul. 1991).
Itamura, S. et al., Gene 38:57-64 (1985).
Iwatsuki, K. et al., Jpn. J. Dermatol. 99:1059-1065 (1989).
Kiyokawa, T. et al., Proc. Natl. Acad. Sci. USA 81:6202-6206 (1984).
Kline, R.L. et al., Lancet 337:30-33 (1991).
Lal, R.B. et al., J. Infect. Dis. 163:41-46 (1991).
Lal, R.B. et al., J. Clin. Microbiol. 29,10:2253-2258 (1991).
Lee, T.H. et al., Proc. Natl. Acad. Sci. USA 81:3856-3860 (1984).
Lillehoj, E.P. et al., J. Clin. Microbiol. 28,12:2653-2658 (1990).
Newman, M.J. et al., Virology 150:106-116 (1986).
Nyunoya, H. et al., AIDS Res. H. Retroviruses 6,11:1311-1321 (1990).
Oroszlan, S. and Copeland, T.D., Current Topics in Microbiol. and Immunol. 115:221-233 (1985).
Palker, T.J. et al., J. Immunol. 142:971-978 (1989).
Patarca, R. and Haseltine, W. A., Nature 309:728 (1984).
Poiesz, B.J. et al., Proc. Natl. Acad. Sci. USA 77:7415-7419 (1980).
Poiesz, B.J. et al., Nature 294:268-271 (1981).
Ralston, S. et al., J. Biol. Chem. 264,28:16343-16346 (1989).
Robert-Guroff, M. et al., J. Exper. Med. 154:1957-1964 (1981).
Robert-Guroff M. et al., J. Exper. Med. 157:248-258 (1983).
Robert-Guroff, M. and Shephard, E., J. Virology 53,1:214-220 (1985).
Samuel, K.P. et al., Science 226:1094-1097 (1984).
Saxinger, W. et al., Science (Sep. 28) 225:1473-1476 (1984).
Schupbach, J. et al., Science 224:607-610 (1984).
Seiki, M. et al., Proc. Natl. Acad. Sci.USA 80:3618-3622 (1983).
Shimoyama, M. et al., Jpn. J. Clin. Oncol. 12,1:109-116 (1982).
Slamon, D.J. et al., Science 226:61-65 (1984).
Sodroski, J. et al., Science 225:421-424 (1984).
Sugamura, K. et al., J. Immun. 132,6:3180-3184 (1984).
Tanaka, Y. et al., Int. J. Cancer 36:549-555 (1985).
Tanaka, Y. et al., Int. J. Cancer 46:675-681 (1990).
Viscidi, R.P. et al., J. AIDS 4:1190-1198 (1991).
Washitani et al., Int. J. Cancer 49:173-177 (1991).
Wiktor S.Z. et al., Lancet 335:1533 (1990).
Wiktor S.Z. et al., Lancet 338:512-513 (1991).
Williams, A. E. et al., Science 240:643-646 (1988).
Williams, A. E. et al., MMWR 39,50:915-924 (1990).
Yoshida, M. et al., Proc. Natl. Acad. Sci. USA 79:2031-2035 (1982).

Affiliated with

Also associated with

Rating

HTLV-I and HTLV-II peptide antigens and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HTLV-I and HTLV-II peptide antigens and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HTLV-I and HTLV-II peptide antigens and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-877342